chr12-45852615-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_152641.4(ARID2):​c.4492G>A​(p.Ala1498Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000915 in 1,614,160 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0050 ( 3 hom., cov: 32)
Exomes 𝑓: 0.00049 ( 10 hom. )

Consequence

ARID2
NM_152641.4 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: 2.44

Publications

3 publications found
Variant links:
Genes affected
ARID2 (HGNC:18037): (AT-rich interaction domain 2) This gene encodes a member of the AT-rich interactive domain (ARID)-containing family of DNA-binding proteins. Members of the ARID family have roles in embryonic patterning, cell lineage gene regulation, cell cycle control, transcriptional regulation and chromatin structure modification. This protein functions as a subunit of the polybromo- and BRG1-associated factor or PBAF (SWI/SNF-B) chromatin remodeling complex which facilitates ligand-dependent transcriptional activation by nuclear receptors. Mutations in this gene are associated with hepatocellular carcinomas. A pseudogene of this gene is found on chromosome1. [provided by RefSeq, Dec 2016]
ARID2 Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Illumina, Orphanet, ClinGen
  • Coffin-Siris syndrome 6
    Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0030726194).
BP6
Variant 12-45852615-G-A is Benign according to our data. Variant chr12-45852615-G-A is described in ClinVar as Benign. ClinVar VariationId is 133570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00496 (756/152308) while in subpopulation AFR AF = 0.0172 (715/41580). AF 95% confidence interval is 0.0162. There are 3 homozygotes in GnomAd4. There are 347 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 756 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARID2NM_152641.4 linkc.4492G>A p.Ala1498Thr missense_variant Exon 15 of 21 ENST00000334344.11 NP_689854.2
ARID2NM_001347839.2 linkc.4492G>A p.Ala1498Thr missense_variant Exon 15 of 20 NP_001334768.1 Q68CP9
ARID2XM_047428489.1 linkc.4492G>A p.Ala1498Thr missense_variant Exon 15 of 17 XP_047284445.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARID2ENST00000334344.11 linkc.4492G>A p.Ala1498Thr missense_variant Exon 15 of 21 1 NM_152641.4 ENSP00000335044.6 Q68CP9-1

Frequencies

GnomAD3 genomes
AF:
0.00497
AC:
757
AN:
152190
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0173
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00223
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00127
AC:
319
AN:
250962
AF XY:
0.000959
show subpopulations
Gnomad AFR exome
AF:
0.0175
Gnomad AMR exome
AF:
0.000839
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000265
Gnomad OTH exome
AF:
0.000491
GnomAD4 exome
AF:
0.000493
AC:
721
AN:
1461852
Hom.:
10
Cov.:
32
AF XY:
0.000422
AC XY:
307
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.0180
AC:
602
AN:
33476
American (AMR)
AF:
0.000805
AC:
36
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000144
AC:
16
AN:
1111982
Other (OTH)
AF:
0.00103
AC:
62
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
49
98
146
195
244
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00496
AC:
756
AN:
152308
Hom.:
3
Cov.:
32
AF XY:
0.00466
AC XY:
347
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.0172
AC:
715
AN:
41580
American (AMR)
AF:
0.00222
AC:
34
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68018
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
44
89
133
178
222
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00361
Hom.:
1
Bravo
AF:
0.00558
ESP6500AA
AF:
0.0161
AC:
71
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00161
AC:
196
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 13, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

ARID2-related disorder Benign:1
Jan 06, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
18
DANN
Uncertain
0.98
DEOGEN2
Benign
0.014
T;T;.;.
Eigen
Benign
-0.23
Eigen_PC
Benign
-0.018
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.72
T;.;T;T
MetaRNN
Benign
0.0031
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N;.;.;.
PhyloP100
2.4
PrimateAI
Benign
0.36
T
PROVEAN
Benign
0.16
N;N;N;N
REVEL
Benign
0.053
Sift
Benign
0.15
T;T;T;T
Sift4G
Benign
0.76
T;T;T;T
Polyphen
0.0010
B;.;B;.
Vest4
0.049
MVP
0.16
MPC
0.12
ClinPred
0.0059
T
GERP RS
4.6
PromoterAI
0.0062
Neutral
Varity_R
0.059
gMVP
0.13
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116531573; hg19: chr12-46246398; COSMIC: COSV99044039; API